3.64

0.83% 0.03

Mimedx Group Inc (MDXG)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Mimedx Group Inc stock is traded at $3.64, with a volume of 1.92M. It is up +0.83% in the last 24 hours and down -7.14% over the past month. MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Previous Close:

$3.61

Open:

$3.59

24h Volume:

1.92M

Relative Volume:

1.47

Market Cap:

$542.16M

Revenue:

$418.63M

Net Income/Loss:

$48.58M

P/E Ratio:

11.22

EPS:

0.3244

Net Cash Flow:

$70.88M

1W Performance:

+7.06%

1M Performance:

-7.14%

6M Performance:

-54.27%

1Y Performance:

-45.02%

1-Day Range:

$3.59

$3.73

1-Week Range:

$3.025

$3.73

52-Week Range:

$3.025

$7.99

Mimedx Group Inc Stock (MDXG) Company Profile

Name

Mimedx Group Inc

Sector

Healthcare (1106)

Industry

Biotechnology (615)

Phone

(770) 651-9100

Address

1775 W OAK COMMONS COURT, NE, MARIETTA

Employee

808

Twitter

Next Earnings Date

2026-04-29

Latest SEC Filings

MDXG's Discussions on Twitter

Compare MDXG vs MOBBW, GOODO, SHMD, PSNYW, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDXG	6.49	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	2.485	3.30B	0	0	0	0.00
GOODO Gladstone Commercial Corporation	20.13	372.90M	0	0	0	0.00
SHMD Schmid Group N V	5.29	305.77M	52.15M	-21.46M	0	-0.4675
PSNYW Polestar Automotive Holding Uk	3.09	285.84M	2.07B	-1.42B	-1.37B	-0.6765
DWLD Davis Select Worldwide ETF	47.06	0	0	0	0	0.00

Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-23-26	Initiated	Citizens	Mkt Outperform
Jul-02-24	Initiated	Cantor Fitzgerald	Overweight
Mar-07-24	Initiated	Lake Street	Buy
Oct-27-23	Initiated	Craig Hallum	Buy
Oct-13-22	Initiated	Mizuho	Buy
Jul-26-21	Initiated	Northland Capital	Outperform
Mar-19-21	Initiated	H.C. Wainwright	Buy

View All

Mimedx Group Inc Stock (MDXG) Latest News

May 05, 2026

How Reimbursement Shifts Are Rewriting The MiMedx Group (MDXG) Investment Narrative - Yahoo Finance

May 05, 2026

U.S. Perinatal Tissue-derived Allograft Market Detailed In New - openPR.com

May 05, 2026

MSN Money - MSN

May 05, 2026

May 03, 2026

MiMedx Group, Inc. (NASDAQ:MDXG) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

May 03, 2026

May 02, 2026

MiMedx Launches CHORIOFIX Placental Allograft for Complex Wound Care - HarianBasis.co

May 02, 2026

MiMedx Group (NASDAQ:MDXG) Stock Rating Lowered by Wall Street Zen - MarketBeat

May 02, 2026

May 01, 2026

MiMedx Group (NASDAQ:MDXG) Stock Price Up 7%Still a Buy? - MarketBeat

May 01, 2026

MiMedx Reports Q1 Revenue Drop Amid Medicare Reimbursement Shift - HarianBasis.co

May 01, 2026

MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds - Insider Monkey

May 01, 2026

Apr 30, 2026

MiMedx Group (MDXG) price target decreased by 17.24% to 8.16 - MSN

Apr 30, 2026

MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $6.00 at Citizens Jmp - MarketBeat

Apr 30, 2026

Q1 2026 MiMedx Group Inc Earnings Call Transcript - GuruFocus

Apr 30, 2026

New Medicare payment rules hit MIMEDX wound sales 60%, cut 2026 view - Stock Titan

Apr 30, 2026

Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption - MSN

Apr 30, 2026

Citizens cuts MiMedx stock price target to $6 on Medicare headwinds - Investing.com Australia

Apr 30, 2026